Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04179825 · ClinicalTrials.gov registry record
Parents' and Clinicians' Perspectives of the Quick Parenting Assessment (QPA)
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 582
- Enrollment target
NCT04179825: Completed study, sponsored by Vanderbilt University Medical Center.
NCT04179825 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 582 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04179825 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 582 participants
- Enrollment target
Study Summary
A quality improvement (QI) study that integrates an adverse childhood experiences (ACEs) instrument, including the Quick Parenting Assessment (QPA), into pediatric primary care visit.
Primary Outcome
Parents provide feedback regarding whether the new ACEs screening tool works for them using a questionnaire. The questionnaire included questions about whether the ACEs assessment worked for the parent and whether it was culturally sensitive.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 582 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2022-03-04 |
What the finished NCT04179825 record still lists
NCT04179825 is an observational study that tracks outcomes without assigning an intervention. The registered 582 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04179825 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04179825 about?
NCT04179825 is a clinical study titled "Parents' and Clinicians' Perspectives of the Quick Parenting Assessment (QPA)". A quality improvement (QI) study that integrates an adverse childhood experiences (ACEs) instrument, including the Quick Parenting Assessment (QPA), into pediatric primary care visit.
What is the current status of trial NCT04179825?
This trial is currently completed. The enrollment target is 582 participants. The study started on 2018-12-18. Estimated completion is 2022-03-04.
Who is sponsoring clinical trial NCT04179825?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06350097 · 582 participants · Phase 3
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- NCT06563895 · 582 participants · Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- NCT06819007 · 582 participants · Phase 3
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI